Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

New Target Timelines And Deadlines Increase Initiation Speed Of NCI Sponsored Clinical Trials

Date: Jun-19-2013
The National Cancer Institute (NCI) and investigators have reduced the deadlines for initiation of trials with the goal of reaching more patients in need of new treatments, according to a study published in the Journal of the National Cancer Institute. In the year 2008, the NCI created the Operational Efficiency Working Group (OWEG) to develop recommendations for increasing the speed at which NCI-sponsored trials are initiated...

Association Between Eating Behaviors In Preschoolers And Later Cardiovascular Risk

Date: Jun-19-2013
Eating behaviors of preschoolers may be associated with risk of cardiovascular disease in later life, suggests a study published in CMAJ (Canadian Medical Association Journal). A study of 1076 preschool children aged 3-5 years in the TARGet Kids! practice-based research network in Toronto, Ontario, looked at the link between eating habits and serum levels of non-high-density lipoprotein (HDL) cholesterol, which is a surrogate marker of later cardiovascular risk...

Improving Health Care Access In Developing Countries, Remote Regions, Using Mobile Health Devices

Date: Jun-19-2013
Mobile health technology has substantial potential for improving access to health care in the developing world and in remote regions of developed countries, states an article in CMAJ (Canadian Medical Association Journal). In many countries, access to health care is hampered by lack of medical professionals and health care infrastructure, limited or poor equipment, sporadic power and other obstacles. However, the development of remote-presence medical devices can help fill this void by connecting people in remote locations with experienced health care professionals for real-time assessment...

Heart Failure And Hypertension Meds May Help Decrease Obesity

Date: Jun-19-2013
A type of drug normally used to treat heart failure and high blood pressure helped prevent weight gain and other complications related to a high-fat diet in an animal study. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. Weight gain, especially around the waist, and high blood pressure, combine with other abnormalities to form a cluster of diseases known as metabolic syndrome, which increases the risk of heart disease, diabetes and other serious illnesses...

In Obese And Overweight Children, Vitamin D Deficiency Linked To Increased Allergy Risk And Severity

Date: Jun-19-2013
One reason why obese children and teenagers are more likely to have hard-to-control asthma and allergies may be vitamin D deficiency, a new study finds. Results of the study were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. "The increased risk for asthma and allergies, and for more severe cases of allergic disease, in overweight and obese adolescents has not previously been understood," said Candace Percival, MD, lead investigator and a pediatric endocrinology fellow at Walter Reed National Military Medical Center, Bethesda, MD...

Diagnostic Genetic Tool Identifies Benign Thyroid Growths, Potentially Avoiding Thousands Of Unnecessary Surgeries

Date: Jun-19-2013
A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. "We have developed a 'gene signature' that effectively identifies benign thyroid nodules," said Hernan Gonzalez, MD, PhD, associate professor at the Pontifical Catholic University of Chile in Santiago. "This test is potentially useful to identify patients who do not require surgery...

Advanced Hormone-Sensitive Breast Cancer Responds To Osteoporosis Drug

Date: Jun-19-2013
A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. The medication, bazedoxifene, which is approved in Europe under the brand name Conbriza for the treatment and prevention of postmenopausal osteoporosis, also reduced estrogen activity and estrogen receptor levels in cultured human breast cancer cells, the study authors reported...

Girls With Anorexia Nervosa Suffer Reduced Anxiety With Estrogen Replacement Therapy

Date: Jun-19-2013
Estrogen replacement therapy is associated with a significant decrease in anxiety symptoms among girls with anorexia nervosa, a new clinical trial finds. The results were presented today at The Endocrine Society's Annual Meeting in San Francisco...

Healthcare Inflation Slowing Down, USA

Date: Jun-19-2013
Despite newly insured people being added to the system, American healthcare inflation is expected to fall to 6.5% in 2014, says a new report by the Health Research Institute, part of PricewaterhouseCoopers LLP. Healthcare inflation in 2014 will drop even lower than this year "Defying historical patterns", the authors wrote. Continued downward pressure is expected for the health sector, mainly because of aggressive and creative steps taken by employers, elements of the ACA (Affordable Care Act), and new locations and models for delivering care...

New Drug Developed That Reverses Loss Of Brain Connections In Alzheimer's

Date: Jun-19-2013
The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines to stop the destructive cascade of changes in the brain that destroys the connections between neurons, leading to memory loss and cognitive decline. The decade-long study, led by Stuart A. Lipton, M.D., Ph.D., professor and director of the Del E...